سعر سيفاكلور 250 مجم 12 كبسولة 2022

Cefaclor 250mg 12 caps. (n/a): Cefaclor (Pharco B).

• Oral cefaclor is indicated for infections due to susceptible organisms including certain staphylococci (methicillin-susceptible), streptococci (including S. pneumoniae and S. pyogenes), and selected Gram-negative bacteria such as E. coli, H. influenzae, Klebsiella spp., and P. mirabilis (US cefaclor suspension/capsule labels). Select therapy by culture and susceptibility when feasible.Population: Per referenced label / class informationDailyMed (U.S. National Library of Medicine)

• Hypersensitivity reactions reported in about 1.5% of patients (e.g. morbilliform eruptions); pruritus, urticaria, positive Coombs tests also reported. Gastrointestinal effects (diarrhea, nausea, vomiting) and other reactions may occur (US labels).International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)

• Contraindicated in patients with known allergy to the cephalosporin group of antibiotics (US cefaclor labels).International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)

• Before therapy, inquire about prior hypersensitivity to cefaclor, other cephalosporins, penicillins, or other drugs; cross-hypersensitivity among beta-lactams may occur. Clostridioides difficile-associated diarrhea reported with nearly all antibacterials including cefaclor. Prolonged use may result in overgrowth of nonsusceptible organisms.International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)

• Historical US Pregnancy Category B wording: animal studies at multiples of human dose revealed no fetal harm; no adequate well-controlled studies in pregnant women — use only if clearly needed (US cefaclor labels).International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)

• Cefaclor: Bactericidal; inhibits bacterial cell-wall synthesis like other cephalosporins; inactive against methicillin-resistant staphylococci.